Editorials

Ten years of the Global Alliance for Vaccines and Immunisation

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2004 (Published 20 April 2010) Cite this as: BMJ 2010;340:c2004
  1. Kelley Lee, reader in global health,
  2. Andrew Harmer, research fellow
  1. 1London School of Hygiene and Tropical Medicine, London WC1E 7HT
  1. kelley.lee{at}lshtm.ac.uk

    Successes of immunisation are tempered by slow progress in strengthening health systems

    The Global Alliance for Vaccines and Immunisation (GAVI), now known as the GAVI Alliance, was created in 2000 to increase the availability and use of immunisation in poor countries. GAVI’s launch, which was made possible by a start-up grant of $750m (£486m; €550m) from the Gates Foundation, was part of broader efforts by world leaders to strengthen public health action across the globe in the late 1990s. Nine million children die in the developing world annually, two million from diseases for which vaccines are available. Over the past decade, GAVI has immunised 256 million children and, in doing so, has averted five million deaths.1

    For many, the measurable achievements of GAVI make it the flagship among a flood of global public-private partnerships in health. The alliance has achieved this by playing a “market shaping role”—for example, by consolidating populations into larger markets and exerting downward pressure on prices (as it did for hepatitis B and diphtheria-pertussis-tetanus vaccines) through its purchasing power. It has also politicised vaccines, in …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe